Child-sized Tamiflu capsules receive EU approval

zoom

The European Commission has approved smaller child sized Tamiflu (oseltamivir) capsules of 30 mg and 45 mg doses.

Until now, Roche's Tamiflu was available in capsules containing a 75 mg dose of oseltamivir and as a powder for oral suspension for use in children. The new lower dose capsules provide a convenient alternative for the treatment and prevention of influenza types A and B in children one year and older.

Since the smaller capsules have a longer shelf life than the suspension formulation (five years vs. two years), they also offer an improved option for government pandemic stockpiling.

The lower dose Tamiflu capsules were approved by the US Food and Drug Administration (FDA) in July.

As well as being used to manage seasonal influenza, Roche expects the 30 mg and 45 mg capsules to be an important component in government pandemic preparedness.

Print | Email | Discuss this article

| Share |

READERS' COMMENTS

Click here to post a comment

Add your Comment All posts are sent to the administrator for review and are published only after approval. ArabianBusiness.com reserves the right to remove any comment at any time for any reason. Please keep your responses appropriate and on topic.
Name *
Remember me on this computer
Email *	(Your email address will not be published)
City
Country
Subject *
Comment *
Notify me of further comments
Enter the words above *
Please click post only once - your comment will not be published immediately.

MORE FROM ARABIANBUSINESS.COM